Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bishop

Showing results (461-470 of 533) with videos related to

Pageof 54
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
The Journal of Clinical Investigation|October 1, 1995
Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblastsP D Cotter, A May, E J Fitzsimons, et al.
Inflammatory Bowel Diseases|June 11, 2013
Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencingJosef Wagner, Jovana Maksimovic, Gabriella Farries, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
Health Services Research|February 6, 2016
A Randomized, Controlled Trial of a Shared Panel Management Program for Small PracticesTara F Bishop, Andrew M Ryan, Melinda A Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapyJ F Bishop, J P Matthews, M M Wolf, et al.
Inflammatory Bowel Diseases|May 23, 2009
Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's diseaseCarl D Kirkwood, Josef Wagner, Karen Boniface, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancerJ F Bishop, R Kefford, D Raghavan, et al.
Pageof 54

Showing results (461-470 of 533) with videos related to

Sort By:
Pageof 54
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Australian and New Zealand Journal of Medicine|February 1, 1986
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
The Journal of Clinical Investigation|October 1, 1995
Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblastsP D Cotter, A May, E J Fitzsimons, et al.
Inflammatory Bowel Diseases|June 11, 2013
Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencingJosef Wagner, Jovana Maksimovic, Gabriella Farries, et al.
American Journal of Clinical Oncology|June 17, 1998
Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I studyG C Toner, M Green, J F Bishop, et al.
Health Services Research|February 6, 2016
A Randomized, Controlled Trial of a Shared Panel Management Program for Small PracticesTara F Bishop, Andrew M Ryan, Melinda A Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapyJ F Bishop, J P Matthews, M M Wolf, et al.
Inflammatory Bowel Diseases|May 23, 2009
Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's diseaseCarl D Kirkwood, Josef Wagner, Karen Boniface, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancerJ F Bishop, R Kefford, D Raghavan, et al.
Pageof 54